Compositions and methods for accurately identifying mutations
US-2024409996-A1 · Dec 12, 2024 · US
US10047366B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10047366-B2 |
| Application number | US-201414772832-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 6, 2014 |
| Priority date | Mar 6, 2013 |
| Publication date | Aug 14, 2018 |
| Grant date | Aug 14, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the field of chromosome engineering. More specifically, the present invention provides methods and compositions useful for inducibly linearizing circular DNA molecules in vivo in yeast. In one embodiment, a comprises a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding a selectable marker comprises an intron comprising an endonuclease recognition site flanked by telomere seed sequences.
Opening claim text (preview).
We claim: 1. A telomerator cassette comprising a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding a selectable marker is interrupted by an intron comprising an endonuclease recognition site flanked by telomere seed sequences. 2. The telomerator cassette of claim 1 , wherein the intron is the ACT1 intron. 3. The telomerator cassette of claim 1 , wherein the selectable marker is an auxotrophic marker. 4. The telomerator cassette of claim 3 , wherein the auxotrophic marker is the URA3 gene. 5. The telomerator cassette of claim 1 , wherein the endonuclease recognition site is specific for I-SceI. 6. The telomerator cassette of claim 5 , wherein the I-SceI endonuclease recognition site comprises SEQ ID NO:2. 7. The telomerator cassette of claim 1 , wherein the telomere seed sequences comprise SEQ ID NO:1 and SEQ ID NO:3. 8. A circular chromosome comprising the telomerator cassette of claim 1 . 9. A eukaryotic host cell comprising the circular chromosome of claim 8 . 10. The eukaryotic host cell of claim 9 , wherein the eukaryote is yeast. 11. The eukaryotic host cell of claim 10 , wherein the yeast is S. cerevisiae. 12. The eukaryotic host cell of claim 9 , wherein the host cell comprises a vector encoding the endonuclease under the control of an inducible promoter. 13. A telomerator cassette comprising a nucleic acid that encodes the auxotrophic marker URA3, wherein the nucleic acid is interrupted by an intron that comprises the I-SceI endonuclease recognition site flanked by telomere seed sequences. 14. The telomerator cassette of claim 13 , wherein the telomere seed sequences comprise SEQ ID NO:1 and SEQ ID NO:3. 15. The telomerator cassette of claim 13 , wherein the I-SceI endonuclease recognition site comprises SEQ ID NO:2. 16. A circular chromosome comprising the telomerator cassette of claim 13 . 17. A yeast host cell comprising the circular chromosome of claim 16 . 18. The yeast host cell of claim 17 , wherein the yeast host cell comprises a vector encoding the I-SceI endonuclease under the control of an inducible promoter. 19. The yeast host cell of claim 18 , wherein the inducible promoter is the GAL1 promoter. 20. A yeast host cell comprising: a. a circular chromosome comprising a telomerator cassette encoding a selectable marker, wherein the nucleic acid encoding the selectable marker is interrupted by an intron that comprises an endonuclease recognition site flanked by telomere seed sequences; and b. a vector encoding the endonuclease under the control of an inducible promoter. 21. The yeast host cell of claim 20 , wherein the selectable marker is an auxotrophic marker. 22. The yeast host cell of claim 21 , wherein the auxotrophic marker is the URA3 gene. 23. The yeast host cell of claim 20 , wherein the endonuclease recognition site is specific for I-SceI. 24. The yeast host cell of claim 23 , wherein the I-SceI endonuclease recognition site comprises SEQ ID NO:2. 25. The yeast host cell of claim 20 , wherein the telomere seed sequences comprise SEQ ID NO:1 and SEQ ID NO:3. 26. A method for engineering a circular chromosome capable of being inducibly linearized comprising the step of integrating a telomerator cassette into a circular chromosome, wherein the telomerator cassette comprises a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding a selectable marker is interrupted by an intron comprising an endonuclease recognition site flanked by telomere seed sequences. 27. The method of claim 26 , wherein the integrating step is accomplished by transforming a telomerator cassette into a host cell comprising the circular chromosome. 28. The method of claim 27 , wherein the host cell comprises a vector encoding the endonuclease under the control of an inducible promoter. 29. A telomerator cassette comprising a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding the selectable marker is interrupted by an endonuclease recognition site flanked by telomere seed sequences such that the selectable marker retains its function. 30. The telomerator cassette of claim 29 , wherein the selectable marker is an auxotrophic marker. 31. The telomerator cassette of claim 30 , wherein the auxotrophic marker is the URA3 gene. 32. The telomerator cassette of claim 29 , wherein the endonuclease recognition site is specific for I-SceI. 33. The telomerator cassette of claim 32 , wherein the I-SceI endonuclease recognition site comprises SEQ ID NO:2. 34. The telomerator cassette of claim 29 , wherein the telomere seed sequences comprise SEQ ID NO:1 and SEQ ID NO:3. 35. A circular chromosome comprising the telomerator cassette of claim 29 . 36. A eukaryotic host cell comprising the circular chromosome of claim 35 .
Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites · CPC title
using markers (enzymes used as markers C12N15/52) · CPC title
for yeasts · CPC title
in yeast · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.